These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26631113)

  • 21. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
    Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
    Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoformulation of EPZ011989 Attenuates EZH2-c-Myb Epigenetic Interaction by Proteasomal Degradation in Acute Myeloid Leukemia.
    Kaundal B; Srivastava AK; Dev A; Mohanbhai SJ; Karmakar S; Roy Choudhury S
    Mol Pharm; 2020 Feb; 17(2):604-621. PubMed ID: 31904978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia.
    Man N; Mas G; Karl DL; Sun J; Liu F; Yang Q; Torres-Martin M; Itonaga H; Martinez C; Chen S; Xu Y; Duffort S; Hamard PJ; Chen C; Zucconi BE; Cimmino L; Yang FC; Xu M; Cole PA; Figueroa ME; Nimer SD
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
    Klempnauer KH
    Exp Hematol; 2022 Apr; 108():8-15. PubMed ID: 35032593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.
    Sandberg ML; Sutton SE; Pletcher MT; Wiltshire T; Tarantino LM; Hogenesch JB; Cooke MP
    Dev Cell; 2005 Feb; 8(2):153-66. PubMed ID: 15691758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of MYB by distal enhancer elements in human myeloid leukemia.
    Li M; Jiang P; Cheng K; Zhang Z; Lan S; Li X; Zhao L; Wang Y; Wang X; Chen J; Ji T; Han B; Zhang J
    Cell Death Dis; 2021 Feb; 12(2):223. PubMed ID: 33637692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
    Walf-Vorderwülbecke V; Pearce K; Brooks T; Hubank M; van den Heuvel-Eibrink MM; Zwaan CM; Adams S; Edwards D; Bartram J; Samarasinghe S; Ancliff P; Khwaja A; Goulden N; Williams G; de Boer J; Williams O
    Leukemia; 2018 Apr; 32(4):882-889. PubMed ID: 29089643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.
    Zhao L; Glazov EA; Pattabiraman DR; Al-Owaidi F; Zhang P; Brown MA; Leo PJ; Gonda TJ
    Nucleic Acids Res; 2011 Jun; 39(11):4664-79. PubMed ID: 21317192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
    Jones M; Grosche P; Floersheimer A; André J; Gattlen R; Oser D; Tinchant J; Wille R; Chie-Leon B; Gerspacher M; Ertl P; Ostermann N; Altmann E; Manchado E; Vorherr T; Chène P
    Biochemistry; 2023 Apr; 62(7):1321-1329. PubMed ID: 36883372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
    Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.
    Bengtsen M; Sørensen L; Aabel L; Ledsaak M; Matre V; Gabrielsen OS
    Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):751-760. PubMed ID: 28495617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.
    Sykes DB; Kfoury YS; Mercier FE; Wawer MJ; Law JM; Haynes MK; Lewis TA; Schajnovitz A; Jain E; Lee D; Meyer H; Pierce KA; Tolliday NJ; Waller A; Ferrara SJ; Eheim AL; Stoeckigt D; Maxcy KL; Cobert JM; Bachand J; Szekely BA; Mukherjee S; Sklar LA; Kotz JD; Clish CB; Sadreyev RI; Clemons PA; Janzer A; Schreiber SL; Scadden DT
    Cell; 2016 Sep; 167(1):171-186.e15. PubMed ID: 27641501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish.
    Liu W; Wu M; Huang Z; Lian J; Chen J; Wang T; Leung AY; Liao Y; Zhang Z; Liu Q; Yen K; Lin S; Zon LI; Wen Z; Zhang Y; Zhang W
    Leukemia; 2017 Jan; 31(1):222-233. PubMed ID: 27457538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
    Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
    Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-MYB and DMTF1 in Cancer.
    Fry EA; Inoue K
    Cancer Invest; 2019; 37(1):46-65. PubMed ID: 30599775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants.
    Corradini F; Cesi V; Bartella V; Pani E; Bussolari R; Candini O; Calabretta B
    J Biol Chem; 2005 Aug; 280(34):30254-62. PubMed ID: 15927960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
    Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
    Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.
    Clesham K; Walf-Vorderwülbecke V; Gasparoli L; Virely C; Cantilena S; Tsakaneli A; Inglott S; Adams S; Samarasinghe S; Bartram J; Williams G; de Boer J; Williams O
    Leukemia; 2022 Jun; 36(6):1541-1549. PubMed ID: 35368048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.